miR-217-5p Inhibits Invasion and Metastasis of Prostate Cancer by Targeting Clusterin

Mamm Genome. 2021 Oct;32(5):371-380. doi: 10.1007/s00335-021-09874-4. Epub 2021 May 15.

Abstract

Prostate cancer is not easy to metastasize because it is difficult to diagnose at an early stage, and there is no effective treatment currently. miRNA-217-5p has been reported to be a regulator in the process of prostate cancer. This study aimed to investigate how miRNA-217-5p affects the invasion and migration of prostate cancer. Luciferase assay was used to clarify whether the target gene Clusterin (CLU) was interacted directly with miR-217-5p. miR-217-5p and CLU were knocked down by transfecting respective siRNA into DU145 cells. The expression level of epithelial-mesenchymal transition (EMT)-related proteins was detected by Western blotting. Invasion and migration of DU145 cell were examined by wound healing assay. The results showed that miR-217-5p directly interacted with its target gene CLU, and the transfection of si-CLU and si-miR-217-5p had similar ability to regulate the expression level of EMT-related proteins, which in turn affected the migration and invasion of prostate cancer cell line DU145. In addition, miR-217-5p inhibited the expression of EMT-related proteins by regulating the expression of the target gene CLU, and further inhibited the invasion and migration of prostate cancer cells. Our findings provide a theoretical target basis for the treatment of prostate cancer.

Publication types

  • Retracted Publication

MeSH terms

  • Clusterin / metabolism*
  • Epithelial-Mesenchymal Transition / genetics
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Neoplasm Invasiveness / genetics*
  • Neoplasm Metastasis / genetics*
  • Prostatic Neoplasms / pathology*

Substances

  • Clusterin
  • MIRN217 microRNA, human
  • MicroRNAs